The Oncology Institute Reports Second Quarter 2023 Financial Results and Reaffirms Full Year 2023 Guidance

Go back to The Oncology Institute Reports Second Quarter 2023 Financial Results and Reaffirms Full Year 2023 Guidance

The Oncology Institute, Inc. (TOI) Misses Q2 EPS by 4c, Offers Guidance

August 8, 2023 4:43 PM EDT

The Oncology Institute, Inc. (NASDAQ: TOI) reported Q2 EPS of ($0.19), $0.04 worse than the analyst estimate of ($0.15). Revenue for the quarter came in at $80.2 million versus the consensus estimate of $73.79 million.

GUIDANCE:

The Oncology Institute, Inc. sees FY2023 revenue of $290-320... More